Patterns of Use of medical cannabis among Israeli cancer patients: A single institution experience

Journal of Pain and Symptom Management

Volumn 49, Issue 2, 2015, Pages 223-230

  Waissengrin, Barliz ^a   Urban, Damien ^b   Leshem, Yasmin ^b   Garty, Meital ^a   Wolf, Ido ^a,c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

cancer; Cannabis; chemotherapy; pain; palliative care

Indexed keywords

MEDICAL CANNABIS; ANALGESIC AGENT;

ADULT; AGED; APPETITE; ARTICLE; BREAST CANCER; CANCER PATIENT; COLON CANCER; DELUSION; DIZZINESS; DRUG EFFICACY; DYSPNEA; FATIGUE; FEMALE; HUMAN; ISRAELI; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOOD DISORDER; NAUSEA; PAIN; PANCREAS CANCER; PHYSICIAN; PRESCRIPTION; WELLBEING; ISRAEL; MIDDLE AGED; NEOPLASM; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PHYTOTHERAPY; PROCEDURES; QUESTIONNAIRE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, NON-NARCOTIC; FEMALE; HUMANS; ISRAEL; MALE; MEDICAL MARIJUANA; MIDDLE AGED; NEOPLASMS; PAIN; PALLIATIVE CARE; PHYTOTHERAPY; QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84921828546     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2014.05.018     Document Type: Article

References (22)

1. A. Shelef, M. Mashiah, I. Schumacher, O. Shine, and Y. Baruch Medical grade cannabis (MGC): regulation mechanisms, the present situation around the world and in Israel Harefuah 150 2011 913 917 935, 934
2. D. Turcotte, J.A. Le Dorze, and F. Esfahani Examining the roles of cannabinoids in pain and other therapeutic indications: a review Expert Opin Pharmacother 11 2010 17 31
3. Z. Mehmedic, S. Chandra, and D. Slade Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008 J Forensic Sci 55 2010 1209 1217
4. E.J. Rahn, and A.G. Hohmann Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside Neurotherapeutics 6 2009 713 737
5. D.W. Bowles, C.L. O'Bryant, D.R. Camidge, and A. Jimeno The intersection between cannabis and cancer in the United States Crit Rev Oncol Hematol 83 2012 1 10
6. F.C. Machado Rocha, S.C. Stéfano, R. De Cássia Haiek, L.M. Rosa Oliveira, and D.X. Da Silveira Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis Eur J Cancer Care 17 2008 431 443
7. M. Zutt, H. Hänssle, S. Emmert, C. Neumann, and L. Kretschmer Dronabinol for supportive therapy in patients with malignant melanoma and liver metastases Hautarzt 57 2006 423 427
8. A. Jatoi, H.E. Windschitl, and C.L. Loprinzi Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study J Clin Oncol 20 2002 567 573
9. F. Strasser, D. Luftner, and K. Possinger Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia Study Group J Clin Oncol 24 2006 3394 3400
10. F.A. Campbell, M.R. Tramèr, and D. Carroll Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review BMJ 323 2001 13
11. B. Frank, M.G. Serpell, J. Hughes, J.N. Matthews, and D. Kapur Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study BMJ 336 2008 199
12. V. Maida, M. Ennis, S. Irani, M. Corbo, and M. Dolzhykov Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring J Support Oncol 6 2008 119 124
13. A. Hazekamp, and E.R. Heerdink The prevalence and incidence of medicinal cannabis on prescription in The Netherlands Eur J Clin Pharmacol 69 2013 1575 1580
14. R. Room Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond Addiction 109 2014 345 351
15. J.M. Bostwick, G.M. Reisfield, and R.L. DuPont Clinical decisions. Medicinal use of marijuana N Engl J Med 368 2013 866 868
16. J.N. Adler, and J.A. Colbert Clinical decisions. Medicinal use of marijuana - polling results N Engl J Med 368 2013 e30
17. D.W. Bowles Persons registered for medical marijuana in the United States J Palliat Med 15 2012 9 11
18. G. Bar-Sela, M. Vorobeichik, and S. Drawsheh The medical necessity for medicinal cannabis: prospective, observational study evaluating the treatment in cancer patients on supportive or palliative care Evid Based Complement Alternat Med 2013 2013 510392
19. T.J. Uritsky, M.L. McPherson, and F. Pradel Assessment of hospice health professionals' knowledge, views, and experience with medical marijuana J Palliat Med 14 2011 1291 1295
20. W. Hall, and N. Solowij Adverse effects of cannabis Lancet 352 1998 1611 1616
21. J.R. Johnson, M. Burnell-Nugent, and D. Lossignol Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain J Pain Symptom Manage 39 2010 167 179
22. T.D. Brisbois, I.H. de Kock, and S.M. Watanabe Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial Ann Oncol 22 2011 2086 2093